ALK-Abello A/S (AKBLF)
36.50
0.00 (0.00%)
USD |
OTCM |
Oct 26, 16:00
ALK-Abello Price : 36.50 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 36.50 | 36.50 | 36.50 | 36.50 | 0.000 |
| Oct 23, 2026 | 36.50 | 36.50 | 36.50 | 36.50 | 0.000 |
| Oct 22, 2026 | 36.50 | 36.50 | 36.50 | 36.50 | 0.000 |
| Oct 21, 2026 | 36.50 | 36.50 | 36.50 | 36.50 | 1197.00 |
| Oct 20, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 19, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 16, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 15, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 14, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 13, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 12, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 09, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 08, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 0.000 |
| Oct 07, 2026 | 33.70 | 33.70 | 33.70 | 33.70 | 100.00 |
| Oct 06, 2026 | 31.00 | 31.00 | 31.00 | 31.00 | 0.000 |
| Oct 05, 2026 | 31.00 | 31.00 | 31.00 | 31.00 | 0.000 |
| Oct 02, 2026 | 31.00 | 31.00 | 31.00 | 31.00 | 806.00 |
| Oct 01, 2026 | 31.20 | 31.20 | 31.20 | 31.20 | 100.00 |
| Sep 30, 2026 | 30.50 | 30.50 | 30.50 | 30.50 | 0.000 |
| Sep 29, 2026 | 30.50 | 30.50 | 30.50 | 30.50 | 0.000 |
| Sep 28, 2026 | 30.50 | 30.50 | 30.50 | 30.50 | 0.000 |
| Sep 25, 2026 | 30.50 | 30.50 | 30.50 | 30.50 | 20.00 |
| Sep 24, 2026 | 32.47 | 32.47 | 32.47 | 32.47 | 0.000 |
| Sep 23, 2026 | 32.47 | 32.47 | 32.47 | 32.47 | 553.00 |
| Sep 22, 2026 | 32.47 | 32.47 | 32.47 | 32.47 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 38.90 |
| H. Lundbeck A/S | 6.85 |
| AstraZeneca PLC | 171.18 |
| ANI Pharmaceuticals, Inc. | 72.04 |
| Corcept Therapeutics, Inc. | 86.32 |
Price Related Metrics
| PE Ratio | 38.20 |
| PS Ratio | 7.587 |
| PEG Ratio | 0.8379 |
| Price to Book Value | 7.627 |
| Price to Free Cash Flow | 28.63 |
| Earnings Yield | 2.62% |
| Market Cap | 8.099B |
| PEGY Ratio | 0.8254 |
| Operating PE Ratio | 28.40 |
| Normalized PE Ratio | 38.20 |